Adverum Biotechnologies Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
/ 
Frequently asked questions
To buy Adverum Biotechnologies Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Adverum Biotechnologies Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Adverum Biotechnologies Inc. is ADVM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Adverum Biotechnologies Inc. has its primary listing on NASDAQ. You can trade Adverum Biotechnologies Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Adverum Biotechnologies Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Adverum Biotechnologies Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Adverum Biotechnologies Inc..